{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:04:57Z","timestamp":1790305497588,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903456"],"award-info":[{"award-number":["81903456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272654"],"award-info":[{"award-number":["82272654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cbi.2024.111161","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T12:59:54Z","timestamp":1721739594000},"page":"111161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Ovatodiolide inhibited\u00a0hepatocellular carcinoma stemness through SP1\/MTDH\/STAT3 signaling pathway"],"prefix":"10.1016","volume":"400","author":[{"given":"Tianyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111161_bib1","doi-asserted-by":"crossref","unstructured":"Petrick, J.L., Kelly, S.P., et al., Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J. Clin. Oncol. : official journal of the American Society of Clinical Oncology, 34(15):1787-1794.","DOI":"10.1200\/JCO.2015.64.7412"},{"key":"10.1016\/j.cbi.2024.111161_bib2","doi-asserted-by":"crossref","unstructured":"Anonymous, EASL clinical practice guidelines: management of hepatocellular carcinoma. Journal of hepatology, 69(1):182-236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"10.1016\/j.cbi.2024.111161_bib3","doi-asserted-by":"crossref","unstructured":"Sung, H., Ferlay, J., et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71(3):209-249.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.cbi.2024.111161_bib4","unstructured":"Chidambaranathan-Reghupaty, S., Fisher, P.B., et al., Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv. Cancer Res., 149:1-61."},{"key":"10.1016\/j.cbi.2024.111161_bib5","doi-asserted-by":"crossref","unstructured":"Brown, Z.J., Tsilimigras, D.I., et al., Management of hepatocellular carcinoma: a review. JAMA surgery, 158(4):410-420.","DOI":"10.1001\/jamasurg.2022.7989"},{"key":"10.1016\/j.cbi.2024.111161_bib6","unstructured":"Cai, P.P., Huang, J.W., et al., [Relationship between hepatitis B virus X protein and hepatic cellular cancer]. Yao xue xue bao = Acta pharmaceutica Sinica, 51(2):165-173."},{"key":"10.1016\/j.cbi.2024.111161_bib7","doi-asserted-by":"crossref","unstructured":"Andersson, K.L., Salomon, J.A., et al., Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin. Gastroenterol. Hepatol. : the official clinical practice journal of the American Gastroenterological Association, 6(12):1418-1424.","DOI":"10.1016\/j.cgh.2008.08.005"},{"key":"10.1016\/j.cbi.2024.111161_bib12","doi-asserted-by":"crossref","unstructured":"Song, Q., Ren, W., et al., Long-term outcomes of transarterial chemoembolization combined with radiofrequency ablation versus transarterial chemoembolization alone for recurrent hepatocellular carcinoma after surgical resection. Dig. Dis. Sci., 65(4):1266-1275.","DOI":"10.1007\/s10620-019-05733-0"},{"key":"10.1016\/j.cbi.2024.111161_bib8","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhao, H., et al., FGF19\/SOCE\/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Theranostics, 11(10):5045-5060.","DOI":"10.7150\/thno.56369"},{"key":"10.1016\/j.cbi.2024.111161_bib9","doi-asserted-by":"crossref","unstructured":"Liu, Y.C., Yeh, C.T., et al., Cancer stem cell functions in hepatocellular carcinoma and comprehensive therapeutic strategies. Cells, 9(6).","DOI":"10.3390\/cells9061331"},{"key":"10.1016\/j.cbi.2024.111161_bib10","doi-asserted-by":"crossref","unstructured":"Rawat, D., Shrivastava, S., et al., An overview of natural plant products in the treatment of hepatocellular carcinoma. Anti Cancer Agents Med. Chem., 18(13):1838-1859.","DOI":"10.2174\/1871520618666180604085612"},{"key":"10.1016\/j.cbi.2024.111161_bib11","doi-asserted-by":"crossref","unstructured":"Hou, Y.Y., Wu, M.L., et al., The natural diterpenoid ovatodiolide induces cell cycle arrest and apoptosis in human oral squamous cell carcinoma Ca9-22 cells. Life Sci., 85(1\u20132):26-32.","DOI":"10.1016\/j.lfs.2009.04.013"},{"key":"10.1016\/j.cbi.2024.111161_bib14","doi-asserted-by":"crossref","unstructured":"Huang, Y.J., Yang, C.K., et al., Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J. Hematol. Oncol., 10(1):60.","DOI":"10.1186\/s13045-017-0421-3"},{"key":"10.1016\/j.cbi.2024.111161_bib15","doi-asserted-by":"crossref","unstructured":"Yu, C.Y., Jerry Teng, C.L., et al., Ovatodiolide isolated from Anisomeles indica induces cell cycle G2\/M arrest and apoptosis via a ROS-dependent ATM\/ATR signaling pathways. Eur. J. Pharmacol., 819:16-29.","DOI":"10.1016\/j.ejphar.2017.09.050"},{"key":"10.1016\/j.cbi.2024.111161_bib16","doi-asserted-by":"crossref","unstructured":"Chang, H.L., Chen, H.A., et al., Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro. Toxicol. Vitro : an international journal published in association with BIBRA, 51:74-82.","DOI":"10.1016\/j.tiv.2018.04.010"},{"key":"10.1016\/j.cbi.2024.111161_bib13","doi-asserted-by":"crossref","unstructured":"Lin, K.L., Tsai, P.C., et al., Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Chem. Biol. Interact., 194(2\u20133):148-158.","DOI":"10.1016\/j.cbi.2011.10.002"},{"key":"10.1016\/j.cbi.2024.111161_bib17","doi-asserted-by":"crossref","unstructured":"Liu, M., Bamodu, O.A., et al., Downregulation of cancer stemness by novel diterpenoid ovatodiolide inhibits hepatic cancer stem cell-like traits by repressing wnt\/[formula: see text]-catenin signaling. The American journal of Chinese medicine, 46(4):891-910.","DOI":"10.1142\/S0192415X18500477"},{"key":"10.1016\/j.cbi.2024.111161_bib18","doi-asserted-by":"crossref","unstructured":"Dhiman, G., Srivastava, N., et al., Metadherin: a therapeutic target in multiple cancers. Frontiers in oncology, 9:349.","DOI":"10.3389\/fonc.2019.00349"},{"key":"10.1016\/j.cbi.2024.111161_bib19","doi-asserted-by":"crossref","unstructured":"Hu, G., Wei, Y., et al., The multifaceted role of MTDH\/AEG-1 in cancer progression. Clin. Cancer Res. : an official journal of the American Association for Cancer Research, 15(18):5615-5620.","DOI":"10.1158\/1078-0432.CCR-09-0049"},{"key":"10.1016\/j.cbi.2024.111161_bib20","doi-asserted-by":"crossref","unstructured":"Zhu, K., Peng, Y., et al., Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-\u03b2-catenin signaling pathway. Carcinogenesis, 41(2):130-138.","DOI":"10.1093\/carcin\/bgz065"},{"key":"10.1016\/j.cbi.2024.111161_bib21","doi-asserted-by":"crossref","unstructured":"El-Ashmawy, N.E., El-Zamarany, E.A., et al., Activation of EMT in colorectal cancer by MTDH\/NF-\u03baB p65 pathway. Mol. Cell. Biochem., 457(1\u20132):83-91.","DOI":"10.1007\/s11010-019-03514-x"},{"key":"10.1016\/j.cbi.2024.111161_bib22","doi-asserted-by":"crossref","unstructured":"Yu, H., Zhu, X., et al., A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma. Aging, 12(12):12234-12250.","DOI":"10.18632\/aging.103409"},{"key":"10.1016\/j.cbi.2024.111161_bib23","doi-asserted-by":"crossref","unstructured":"Emdad, L., Sarkar, D., et al., Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res., 66(3):1509-1516.","DOI":"10.1158\/0008-5472.CAN-05-3029"},{"key":"10.1016\/j.cbi.2024.111161_bib24","doi-asserted-by":"crossref","unstructured":"Vogel, A., Meyer, T., et al., Hepatocellular carcinoma. Lancet (London, England), 400(10360):1345-1362.","DOI":"10.1016\/S0140-6736(22)01200-4"},{"key":"10.1016\/j.cbi.2024.111161_bib25","doi-asserted-by":"crossref","unstructured":"Lv, D., Chen, L., et al., Emerging regulatory mechanisms involved in liver cancer stem cell properties in hepatocellular carcinoma. Front. Cell Dev. Biol., 9:691410.","DOI":"10.3389\/fcell.2021.691410"},{"key":"10.1016\/j.cbi.2024.111161_bib26","doi-asserted-by":"crossref","unstructured":"Jordan, M.A., Thrower, D., et al., Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J. Cell Sci., 102 (Pt 3):401-416.","DOI":"10.1242\/jcs.102.3.401"},{"key":"10.1016\/j.cbi.2024.111161_bib27","doi-asserted-by":"crossref","unstructured":"Zhang, X., Li, Y., et al., Beta-elemene blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors. PLoS One, 8(3):e58719.","DOI":"10.1371\/journal.pone.0058719"},{"key":"10.1016\/j.cbi.2024.111161_bib28","doi-asserted-by":"crossref","unstructured":"Tong, L., Li, J., et al., ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics, 10(13):5943-5956.","DOI":"10.7150\/thno.41498"},{"key":"10.1016\/j.cbi.2024.111161_bib29","doi-asserted-by":"crossref","unstructured":"Su, Y.K., Bamodu, O.A., et al., Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide. Phytomedicine : international journal of phytotherapy and phytopharmacology, 61:152840.","DOI":"10.1016\/j.phymed.2019.152840"},{"key":"10.1016\/j.cbi.2024.111161_bib30","doi-asserted-by":"crossref","unstructured":"Rabie, A.M., RNA: the most attractive target in recent viral diseases. Chem. Biol. Drug Des., 103(1):e14404.","DOI":"10.1111\/cbdd.14404"},{"key":"10.1016\/j.cbi.2024.111161_bib31","doi-asserted-by":"crossref","unstructured":"Wang, H., Meng, Q., et al., Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer. Pharmacology & therapeutics, 234:108123.","DOI":"10.1016\/j.pharmthera.2022.108123"},{"key":"10.1016\/j.cbi.2024.111161_bib32","doi-asserted-by":"crossref","unstructured":"Mohammed, Y.H.I., Shamkh, I.M., et al., Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Sci. Rep., 13(1):22824.","DOI":"10.1038\/s41598-023-44662-x"},{"key":"10.1016\/j.cbi.2024.111161_bib33","unstructured":"Nashaan, F.A., S. Al-Rawi, M., et al., Synthesis, characterization, and cytotoxic activity of some imides from galloyl hydrazide. Eurasian Chemical Communications, 4(10):966-975."},{"key":"10.1016\/j.cbi.2024.111161_bib34","unstructured":"Rabie, A.M., Design, Synthesis, and Biological Evaluation of Novel 5-Substituted-2-(3,4,5-Trihydroxyphenyl)-1,3,4-Oxadiazoles as Potent Antioxidants."},{"key":"10.1016\/j.cbi.2024.111161_bib35","unstructured":"Rabie, A.M., Tantawy, A.S., et al., Design, synthesis, and biological evaluation of new 5-Substituted-1,3,4-thiadiazole-2-thiols as potent antioxidants. European Researcher, 10(7):21-43."},{"key":"10.1016\/j.cbi.2024.111161_bib36","doi-asserted-by":"crossref","unstructured":"Rabie, A.M., Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication. ACS Omega, 7(3):2960-2969.","DOI":"10.1021\/acsomega.1c05998"},{"key":"10.1016\/j.cbi.2024.111161_bib37","doi-asserted-by":"crossref","unstructured":"Newman, D.J. and Cragg, G.M., Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. Journal of natural products, 83(3):770-803.","DOI":"10.1021\/acs.jnatprod.9b01285"},{"key":"10.1016\/j.cbi.2024.111161_bib38","doi-asserted-by":"crossref","unstructured":"Xiang, J., Zhang, X., et al., Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile. Chemical communications (Cambridge, England), 56(75):11018-11021.","DOI":"10.1039\/C9CC07573A"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:24:59Z","timestamp":1777389899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724003077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"alternative-id":["S0009279724003077"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111161","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovatodiolide inhibited\u00a0hepatocellular carcinoma stemness through SP1\/MTDH\/STAT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111161"}}